Pharmacokinetics/Pharmacodynamics
on phenytoin metabolism in neurotrauma patients.
J Clin Pharmacol. 1997;37(2):129-139. https://doi.
org/10.1002/j.1552-4604.1997.tb04771.x
Mehta NM, Halwick DR, Dodson BL, Thompson JE,
Arnold JH. Potential drug sequestration during extracor-
poreal membrane oxygenation: results from an ex vivo
https://doi.org/10.1007/s00134-007-0606-2
Moore RD, Lietman PS, Smith CR. Clinical response
to aminoglycoside therapy: importance of the ratio of
peak concentration to minimal inhibitory concentration.
J Infect Dis. 1987;155(1):93-99. https://doi.org/10.1093/
infdis/155.1.93
National Kidney Foundation. K/DOQI clinical practice
guidelines for chronic kidney disease: evaluation, clas-
suppl
1):S1-S266.
https://linkinghub.elsevier.com/
retrieve/pii/S0272638602093563
Nguyen NQ, Ng MP, Chapman M, Fraser RJ, Holloway
RH. The impact of admission diagnosis on gastric emp-
https://doi.org/10.1186/cc5685
Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH,
Ross JW, Quintiliani R. Experience with a once-daily
aminoglycoside program administered to 2,184 adult
patients. Antimicrob Agents Chemother. 1995;39(3):650-
655. https://doi.org/10.1128/aac.39.3.650
Pai MP, Neely M, Rodvold KA, Lodise TP. Innovative
approaches to optimizing the delivery of vancomycin in
individual patients. Adv Drug Deliv Rev. 2014;77:50-57.
https://doi.org/10.1016/j.addr.2014.05.016
Pea F, Pavan F, Furlanut M. Clinical relevance of phar-
macokinetics and pharmacodynamics in cardiac critical
care patients. Clin Pharmacokinet. 2008;47(7):449-462.
https://doi.org/10.2165/00003088-200847070-00002
Petitcollin A, Dequin PF, Darrouzain F, et al.
Pharmacokinetics of high-dose nebulized amikacin in
ventilated critically ill patients. J Antimicrob Chemother.
2016;71(12):3482-3486.
https://doi.org/10.1093/jac/
dkw313
Rabkin R, Ryan MP, Duckworth WC. The renal metabo-
lism of insulin. Diabetologia. 1984;27(3):351-357. https://
doi.org/10.1007/bf00304849
Redl-Wenzl EM, Armbruster C, Edelmann G, et al.
The effects of norepinephrine on hemodynamics and
renal function in severe septic shock states. Intensive
bf01720530
Ritz MA, Fraser R, Edwards N, et al. Delayed gas-
tric emptying in ventilated critically ill patients:
measurement by 13 C-octanoic acid breath test.
org/10.1097/00003246-200109000-00015
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed
therapy in the treatment of severe sepsis and septic
shock. N Engl J Med. 2001;345(19):1368-1377. https://
doi.org/10.1056/nejmoa010307
Roberts JA, Norris R, Paterson DL, Martin JH.
Therapeutic
drug
monitoring
of
antimicrobials.
Br J Clin Pharmacol. 2012;73(1):27-36. https://doi.
org/10.1111/j.1365-2125.2011.04080.x
Roberts JA, Roberts MS, Robertson TA, Dalley AJ,
Lipman J. Piperacillin penetration into tissue of criti-
cally ill patients with sepsis—bolus versus continuous
https://doi.org/10.1097/ccm.0b013e3181968e44
Rommers MK, Van der Lely N, Egberts TC, van
den Bemt PM. Anti-Xa activity after subcutaneous
administration of dalteparin in ICU patients with and
2006;10(3):R93. https://doi.org/10.1186/cc4952
Rondina MT, Wheeler M, Rodgers GM, Draper L,
Pendleton RC. Weight-based dosing of enoxaparin
for VTE prophylaxis in morbidly obese, medically-ill
patients. Thromb Res. 2010;125(3):220-223. https://doi.
org/10.1016/j.thromres.2009.02.003
Ruokonen E, Takala J, Kari A, et al. Regional blood flow
1993;21:1296-1303.
Ruokonen E, Takala J, Kari A, Saxén H, Mertsola J,
Hansen EJ. Regional blood flow and oxygen transport
https://doi.org/10.1097/00003246-199309000-00011
Rybak MJ, Albrecht LM, Berman JR, Warbasse LH,
Svensson CK. Vancomycin pharmacokinetics in burn
patients and intravenous drug abusers. Antimicrob
Agents Chemother. 1990;34(5):792-795. https://doi.
org/10.1128/aac.34.5.792
Rybak MJ, Le J, Lodise TP, et al. Therapeutic moni-
toring of vancomycin for serious methicillin-resistant